2023-2029 Global Meningococcal Disease Vaccine Industry Research & Trends Analysis Report

Tables and Figures

Table 1. Meningococcal Disease Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Meningococcal Disease Vaccine Market Restraints
Table 3. Meningococcal Disease Vaccine Market Trends
Table 4. Meningococcal Disease Vaccine Industry Policy
Table 5. Global Meningococcal Disease Vaccine Revenue by Company, 2018-2023, US$ million
Table 6. Global Meningococcal Disease Vaccine Revenue Market Share by Company, 2018-2023
Table 7. Global Meningococcal Disease Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Meningococcal Disease Vaccine Sales Volume Market Share by Company, 2018-2023
Table 9. Global Meningococcal Disease Vaccine Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Meningococcal Disease Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Meningococcal Disease Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Meningococcal Disease Vaccine Manufacturers Product Type
Table 13. China Meningococcal Disease Vaccine Revenue by Company, 2018-2023, US$ million
Table 14. China Meningococcal Disease Vaccine Revenue Market Share by Company, 2018-2023
Table 15. China Meningococcal Disease Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Meningococcal Disease Vaccine Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Meningococcal Disease Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Meningococcal Disease Vaccine Import & Export Trends
Table 19. Main Sources of China Meningococcal Disease Vaccine Import
Table 20. Export Destination of China Meningococcal Disease Vaccine
Table 21. Global Headquarters and Manufacturing Base of Meningococcal Disease Vaccine Manufacturers
Table 22. Global Major Manufacturers, Meningococcal Disease Vaccine Capacity Expansion and Future Plans
Table 23. Global Meningococcal Disease Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Meningococcal Disease Vaccine Production by Region, 2018-2023, (K Units)
Table 25. Global Meningococcal Disease Vaccine Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Meningococcal Disease Vaccine Upstream (Raw Materials)
Table 27. Global Meningococcal Disease Vaccine Typical Customers
Table 28. Meningococcal Disease Vaccine Typical Distributors
Table 29. By Type, Global Meningococcal Disease Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Meningococcal Disease Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Meningococcal Disease Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Meningococcal Disease Vaccine Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Meningococcal Disease Vaccine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Meningococcal Disease Vaccine Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Meningococcal Disease Vaccine Revenue Market Share, 2018-2029
Table 37. By Country, Global Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Meningococcal Disease Vaccine Sales Volume Market Share, 2018-2029
Table 39. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 40. AstraZeneca Meningococcal Disease Vaccine Models, Specifications and Application
Table 41. AstraZeneca Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. AstraZeneca Company Profile and Main Business
Table 43. AstraZeneca Recent Developments
Table 44. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 45. Johnson & Johnson Meningococcal Disease Vaccine Models, Specifications and Application
Table 46. Johnson & Johnson Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Johnson & Johnson Company Profile and Main Business
Table 48. Johnson & Johnson Recent Developments
Table 49. Mylan N.V Company Information, Head Office, Market Area and Industry Position
Table 50. Mylan N.V Meningococcal Disease Vaccine Models, Specifications and Application
Table 51. Mylan N.V Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Mylan N.V Company Profile and Main Business
Table 53. Mylan N.V Recent Developments
Table 54. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 55. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Models, Specifications and Application
Table 56. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 58. Teva Pharmaceutical Industries Ltd Recent Developments
Table 59. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 60. Pfizer Inc Meningococcal Disease Vaccine Models, Specifications and Application
Table 61. Pfizer Inc Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Pfizer Inc Company Profile and Main Business
Table 63. Pfizer Inc Recent Developments
Table 64. GlaxoSmithKline plc Company Information, Head Office, Market Area and Industry Position
Table 65. GlaxoSmithKline plc Meningococcal Disease Vaccine Models, Specifications and Application
Table 66. GlaxoSmithKline plc Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. GlaxoSmithKline plc Company Profile and Main Business
Table 68. GlaxoSmithKline plc Recent Developments
Table 69. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 70. Novartis AG Meningococcal Disease Vaccine Models, Specifications and Application
Table 71. Novartis AG Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Novartis AG Company Profile and Main Business
Table 73. Novartis AG Recent Developments
Table 74. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 75. Sanofi Meningococcal Disease Vaccine Models, Specifications and Application
Table 76. Sanofi Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Sanofi Company Profile and Main Business
Table 78. Sanofi Recent Developments
Table 79. Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position
Table 80. Merck & Co., Inc. Meningococcal Disease Vaccine Models, Specifications and Application
Table 81. Merck & Co., Inc. Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Merck & Co., Inc. Company Profile and Main Business
Table 83. Merck & Co., Inc. Recent Developments
Table 84. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 85. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Models, Specifications and Application
Table 86. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 88. F. Hoffmann-La Roche Ltd Recent Developments
Table 89. Baxter Company Information, Head Office, Market Area and Industry Position
Table 90. Baxter Meningococcal Disease Vaccine Models, Specifications and Application
Table 91. Baxter Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Baxter Company Profile and Main Business
Table 93. Baxter Recent Developments
Table 94. BIO-MED Company Information, Head Office, Market Area and Industry Position
Table 95. BIO-MED Meningococcal Disease Vaccine Models, Specifications and Application
Table 96. BIO-MED Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. BIO-MED Company Profile and Main Business
Table 98. BIO-MED Recent Developments
Table 99. Bio-Manguinhos Company Information, Head Office, Market Area and Industry Position
Table 100. Bio-Manguinhos Meningococcal Disease Vaccine Models, Specifications and Application
Table 101. Bio-Manguinhos Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Bio-Manguinhos Company Profile and Main Business
Table 103. Bio-Manguinhos Recent Developments
Table 104. Walvax Biotechnology Co., Ltd Company Information, Head Office, Market Area and Industry Position
Table 105. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Models, Specifications and Application
Table 106. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Walvax Biotechnology Co., Ltd Company Profile and Main Business
Table 108. Walvax Biotechnology Co., Ltd Recent Developments
List of Figure
Figure 1. Meningococcal Disease Vaccine Picture
Figure 2. By Revenue, Global Meningococcal Disease Vaccine Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Meningococcal Disease Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Meningococcal Disease Vaccine Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Meningococcal Disease Vaccine Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Meningococcal Disease Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Meningococcal Disease Vaccine Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Meningococcal Disease Vaccine Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Meningococcal Disease Vaccine Share of Global Market, 2018-2029
Figure 10. Global Meningococcal Disease Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Meningococcal Disease Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Meningococcal Disease Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Meningococcal Disease Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Meningococcal Disease Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Meningococcal Disease Vaccine Domestic VS Export, 2022
Figure 16. Global Meningococcal Disease Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Meningococcal Disease Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Meningococcal Disease Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 19. Meningococcal Disease Vaccine Industry Chain
Figure 20. Meningococcal Disease Vaccine Procurement Model
Figure 21. Meningococcal Disease Vaccine Sales Model
Figure 22. Meningococcal Disease Vaccine Sales Channels, Direct Sales and Distribution
Figure 23. Polysaccharide
Figure 24. Conjugate
Figure 25. Combination
Figure 26. By Type, Global Meningococcal Disease Vaccine Revenue, 2018-2029, US$ Million
Figure 27. By Type, Global Meningococcal Disease Vaccine Revenue Market Share, 2018-2029
Figure 28. By Type, Global Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Figure 29. By Type, Global Meningococcal Disease Vaccine Sales Volume Market Share, 2018-2029
Figure 30. By Type, Global Meningococcal Disease Vaccine Price, 2018-2029, (US$/Unit)
Figure 31. Infant
Figure 32. Child
Figure 33. Aldult
Figure 34. By Application, Global Meningococcal Disease Vaccine Revenue, 2018-2029, US$ Million
Figure 35. By Application, Global Meningococcal Disease Vaccine Revenue Market Share, 2018-2029
Figure 36. By Application, Global Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Figure 37. By Application, Global Meningococcal Disease Vaccine Sales Volume Market Share, 2018-2029
Figure 38. By Application, Global Meningococcal Disease Vaccine Price, 2018-2029, (US$/Unit)
Figure 39. By Region, Global Meningococcal Disease Vaccine Revenue Market Share, 2018-2029
Figure 40. By Region, Global Meningococcal Disease Vaccine Sales Volume Market Share, 2018-2029
Figure 41. North America Meningococcal Disease Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, North America Meningococcal Disease Vaccine Revenue Market Share, 2022
Figure 43. Europe Meningococcal Disease Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, Europe Meningococcal Disease Vaccine Revenue Market Share, 2022
Figure 45. Asia Pacific Meningococcal Disease Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country/Region, Asia Pacific Meningococcal Disease Vaccine Revenue Market Share, 2022
Figure 47. South America Meningococcal Disease Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, South America Meningococcal Disease Vaccine Revenue Market Share, 2022
Figure 49. Middle East & Africa Meningococcal Disease Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. U.S. Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Figure 51. By Company, U.S. Meningococcal Disease Vaccine Market Share, 2022
Figure 52. By Type, U.S. Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 54. Europe Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Figure 55. By Company, Europe Meningococcal Disease Vaccine Market Share, 2022
Figure 56. By Type, Europe Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, Europe Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 58. China Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Figure 59. By Company, China Meningococcal Disease Vaccine Market Share, 2022
Figure 60. By Type, China Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, China Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 62. Japan Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Figure 63. By Company, Japan Meningococcal Disease Vaccine Market Share, 2022
Figure 64. By Type, Japan Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, Japan Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 66. South Korea Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Figure 67. By Company, South Korea Meningococcal Disease Vaccine Market Share, 2022
Figure 68. By Type, South Korea Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, South Korea Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 70. Southeast Asia Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Figure 71. By Company, Southeast Asia Meningococcal Disease Vaccine Market Share, 2022
Figure 72. By Type, Southeast Asia Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, Southeast Asia Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 74. India Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Figure 75. By Company, India Meningococcal Disease Vaccine Market Share, 2022
Figure 76. By Type, India Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, India Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 78. Middle East & Asia Meningococcal Disease Vaccine Sales Volume, 2018-2029, (K Units)
Figure 79. By Company, Middle East & Asia Meningococcal Disease Vaccine Market Share, 2022
Figure 80. By Type, Middle East & Asia Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, Middle East & Asia Meningococcal Disease Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 82. Research Methodology
Figure 83. Breakdown of Primary Interviews
Figure 84. Bottom-up Approaches
Figure 85. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets